Solifenacin Succinate Tablet, Film Coated
Product Images NDC 68462-386

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Solifenacin Succinate (NDC 68462-386). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl10mg30

Label for solifenacin succinate tablets, 10 mg extended release, oral tablets, in a package containing 30 tablets. The label includes the NDC 68462-387-30, indicates once-daily dosing, and is manufactured by Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Lbl5mg30

Solifenacin Succinate Tablets 5 mg extended release film-coated tablets packaged in a bottle containing 30 tablets. The label includes the Glenmark Pharmaceuticals Inc., USA logo and details. It notes the usual dosage as once daily and storage instructions. The product is identified by NDC 68462-386-30.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of solifenacin succinate, a molecule combining a bicyclic amine derivative with a succinate group, representing the active ingredient solifenacin succinate.*

FDA Label Image

Glenmark Logo

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.